{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:56:35Z","timestamp":1782604595868,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.07.068","type":"journal-article","created":{"date-parts":[[2011,8,3]],"date-time":"2011-08-03T09:50:46Z","timestamp":1312365046000},"page":"8459-8465","source":"Crossref","is-referenced-by-count":37,"title":["Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4\u20135 years after a previous dose"],"prefix":"10.1016","volume":"29","author":[{"given":"Scott A.","family":"Halperin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Langley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Blatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Dionne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Embree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roehl","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Latiolais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Meekison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Noya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Senders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Zickler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.07.068_bib0005","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1503\/cmaj.050379","article-title":"Changing epidemiology and emerging risk groups for pertussis","volume":"174","author":"Galanis","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3122\/jabfm.19.6.603","article-title":"Pertussis infection in the United States: role for vaccination of adolescents and adults","volume":"19","author":"Brooks","year":"2006","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0015","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1097\/01.inf.0000166163.02135.8b","article-title":"Canadian experience with implementation of an acellular pertussis vaccine booster-dose program in adolescents: implications for the United States","volume":"24","author":"Halperin","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0020","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/655826","article-title":"The present and future control of pertussis","volume":"51","author":"Cherry","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0025","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/655825","article-title":"Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults","volume":"51","author":"Mertsola","year":"2010","journal-title":"Clin Inf Dis"},{"issue":"ACS-5,6","key":"10.1016\/j.vaccine.2011.07.068_bib0030","first-page":"1","article-title":"Prevention of pertussis in adolescents and adults","volume":"29","author":"National Advisory Committee on Immunization (NACI)","year":"2003","journal-title":"Can Commun. Dis. Rep"},{"issue":"RR-3","key":"10.1016\/j.vaccine.2011.07.068_bib0035","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"RR-17","key":"10.1016\/j.vaccine.2011.07.068_bib0040","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adults: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0045","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1016\/j.vaccine.2008.04.089","article-title":"Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling","volume":"26","author":"Bailleux","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0050","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1016\/j.vaccine.2005.06.009","article-title":"Pertussis antitoxin decay after vaccination with DTPa response to a first booster dose 3 1\/2\u20136 1\/2 years after the third vaccine dose","volume":"23","author":"Hallander","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vaccine.2010.10.025","article-title":"A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (BoostrixTM) is immunogenic and well tolerated in adults","volume":"29","author":"Booy","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0060","unstructured":"Sanofi Pasteur Limited. ADACELTM. Tdap vaccine: tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed [Internet]. Silver Spring, MD: US Food and Drug Administration (FDA), Vaccines and Related Biological Products Advisory Committee (VRBPAC); 2005 February 15 [cited 2011 March 18]. Briefing Document No.: 2005-4097B1_6. p. 1\u2013102. Available from: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/05\/briefing\/2005-4097B1_6.pdf"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0065","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1016\/j.vaccine.2006.12.047","article-title":"Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults","volume":"25","author":"McNeil","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0070","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.arcped.2009.01.002","article-title":"Allergic and non-allergic hypersensitivity reactions to toxoid-containing vaccines","volume":"16","author":"Ponvert","year":"2009","journal-title":"Arch P\u00e9diatr"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.inf.0000202082.56403.c4","article-title":"How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?","volume":"25","author":"Halperin","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0080","doi-asserted-by":"crossref","first-page":"8001","DOI":"10.1016\/j.vaccine.2010.09.034","article-title":"The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak","volume":"28","author":"Talbot","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4161\/hv.5.5.6911","article-title":"Safety of Tdap-IPV given one month after TD-IPV booster in healthy young adults","volume":"5","author":"Beytout","year":"2009","journal-title":"Human Vaccines"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0090","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00006454-200004000-00003","article-title":"Adult formulation of a five component acellular pertussis vaccine combined with diptheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immungenic in adolescents and adults","volume":"19","author":"Halperin","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0095","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/INF.0b013e318197fac1","article-title":"Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged children","volume":"28","author":"Waters","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0100","first-page":"796","article-title":"Use of mass Tdap vaccination to control an outbreak of pertussis in a high school\u2014Cook County, Illinois, September 2006\u2013January 2007","volume":"57","author":"Centers for Disease Control and Prevention (CDC)","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1086\/653938","article-title":"Effectiveness of adolescent and adult tetanus, reduced-diphtheria, and acellular pertussis vaccine against pertussis","volume":"51","author":"Wei","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0110","doi-asserted-by":"crossref","first-page":"e14183","DOI":"10.1371\/journal.pone.0014183","article-title":"Seroprevalance of pertussis in the Netherlands: evidence for increased circulation of Bordetella pertussis","volume":"5","author":"de Greeff","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0115","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1016\/j.vaccine.2010.05.070","article-title":"Investigation on a pertussis outbreak in a military school: risk factors and approach to vaccine efficacy","volume":"28","author":"Berger","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0120","first-page":"283","article-title":"A pertussis outbreak among daycare children in Northern Israel: Who gets sick?","volume":"12","author":"Hochwald","year":"2010","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/occmed\/kqq051","article-title":"Outbreak of Bordetella pertussis among oncology nurse specialists","volume":"60","author":"Baugh","year":"2010","journal-title":"Occup Med"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0130","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/bmj.296.6622.612","article-title":"Duration of effectiveness of pertussis vaccine: Evidence from a 10 year community study","volume":"296","author":"Jenkinson","year":"1988","journal-title":"Brit Med J"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0135","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/01.inf.0000160914.59160.41","article-title":"Duration of immunity against pertussis after natural infection or vaccination","volume":"24","author":"Wendelboe","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0140","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1016\/j.vaccine.2007.09.031","article-title":"Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine","volume":"25","author":"Barreto","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0145","unstructured":"Sanofi Pasteur. Menactra\u00ae [product monograph] [Internet]. Toronto (ON): Sanofi Pasteur; 2008 September [cited 2011 March 18]. p. 1\u201341. Available from: https:\/\/www.vaccineshoppecanada.com\/secure\/pdfs\/ca\/menactra_e.pdf."},{"key":"10.1016\/j.vaccine.2011.07.068_bib0150","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1086\/341511","article-title":"Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage","volume":"186","author":"Gilberg","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0155","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0264-410X(01)00393-0","article-title":"International Consensus Group on Pertussis Immunisation Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration","volume":"20","author":"Campins-Mart\u00ed","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0160","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1473-3099(02)00452-8","article-title":"Pertussis of adults and infants","volume":"2","author":"Wirsing von K\u00f6nig","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0165","first-page":"145","article-title":"Pertussis notifications in Australia, 1991 to 1997","volume":"21","author":"Andrews","year":"1997","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0170","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.vaccine.2006.12.017","article-title":"Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting","volume":"25","author":"Forsyth","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0175","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/00063030-200620060-00008","article-title":"Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine (Boostrix\u2122). A review of its use as a single-dose booster immunization","volume":"20","author":"Frampton","year":"2006","journal-title":"Biodrugs"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0180","first-page":"635","article-title":"Indian Academy of Pediatrics Committee on Immunization (IAPCOI) Consensus recommendations on immunization, 2008","volume":"45","author":"Singhal","year":"2008","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0185","doi-asserted-by":"crossref","first-page":"s15","DOI":"10.1590\/S0021-75572006000400003","article-title":"Acellular pertussis vaccine for adolescents","volume":"82","author":"de Carvalho","year":"2006","journal-title":"J Pediatria"},{"key":"10.1016\/j.vaccine.2011.07.068_bib0190","unstructured":"World Health Organization (WHO). Regional consultation to standardize EPI schedule in the Eastern Mediterranean Region of the World Health Organization (WHO EMRO); 2006. Cairo, Egypt: VPI\/EMRO; 2008 March 20 [cited 2011 March 18]. p. 1\u201323. Available from: http:\/\/www.who.int\/immunization\/sage\/3_EMRO_1_EPI_Schedule_Report.pdf."},{"key":"10.1016\/j.vaccine.2011.07.068_bib0195","unstructured":"Bundesgesetz f\u00fcr gesundheit. Impfplan 2011 \u00d6sterreich. [cited 2011 Apr 21]. Available from: http:\/\/www.bmg.gv.at\/cms\/home\/attachments\/7\/3\/0\/CH1081\/CMS1286449898381\/impfplan_2011.pdf."},{"key":"10.1016\/j.vaccine.2011.07.068_bib0200","unstructured":"Calendrier vaccinal recommand\u00e9 au Luxembourg. [cited 2011 April 21]. Available from: http:\/\/www.sante.public.lu\/fr\/rester-bonne-sante\/vaccinations\/calendrie."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T19:20:43Z","timestamp":1543605643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11011133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":40,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X11011133"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.068","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}